PDT Partners, LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1564702 New York, NY

Position in SUPN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,963,227

+$152,579 QoQ

Shares Held

76,673

0.0% QoQ

Ownership

0.132%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

PDT Partners, LLC holds $31,971,918 across 14 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (12.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BCRX	Biocryst Pharmaceuticals Inc	563,440	$5,363,948
2	INDV	Indivior Pharmaceuticals, Inc.	142,792	$4,352,300
3	SUPN	Supernus Pharmaceuticals, Inc. This page	76,673	$3,963,227
4	KNSA	Kiniksa Pharmaceuticals International, plc	80,263	$3,864,663
5	NBIX	Neurocrine Biosciences Inc	28,781	$3,791,608
6	ANIP	Ani Pharmaceuticals Inc	45,442	$3,494,489
7	PCRX	Pacira BioSciences, Inc.	132,368	$2,991,516
8	AMRX	Amneal Pharmaceuticals, Inc.	180,628	$2,245,206

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,963,227	76,673	0.0%	Shares	Sole	2026-05-15
2025-12-31	$3,810,648	76,673	-13.1%	Shares	Sole	2026-02-17
2025-09-30	$4,218,566	88,273	-6.4%	Shares	Sole	2025-11-17
2025-06-30	$2,972,556	94,307	+152.3%	Shares	Sole	2025-08-14
2025-03-31	$1,224,227	37,381	-32.0%	Shares	Sole	2025-05-15
2024-12-31	$1,989,089	55,008	+48.2%	Shares	Sole	2025-02-14
2024-09-30	$1,157,089	37,110	-24.3%	Shares	Sole	2024-11-14
2024-03-31	$1,672,413	49,030	+9.8%	Shares	Sole	2024-05-15
2022-12-31	$1,592,522	44,646	+0.0%	Shares	Sole	2023-02-14
2022-09-30	$1,510,860	44,634	-32.3%	Shares	Sole	2022-11-14
2022-06-30	$1,907,071	65,943	+131.0%	Shares	Sole	2022-08-15
2020-03-31	$513,614	28,550	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.